ResMed Inc. (RSMDF) Gross profit 2017–2026
ResMed Inc. (RSMDF) annual gross profit history from SEC filings — each fiscal year as reported.
$3.5BFY2026 · since FY2017: $1.2B → $3.5B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $3.5B | +13.0% |
| FY2025 | $3.1B | +15.1% |
| FY2024 | $2.7B | +12.7% |
| FY2023 | $2.4B | +16.4% |
| FY2022 | $2.0B | +10.1% |
| FY2021 | $1.8B | +7.1% |
| FY2020 | $1.7B | +15.0% |
| FY2019 | $1.5B | +11.9% |
| FY2018 | $1.3B | +11.1% |
| FY2017 | $1.2B | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More RSMDF financial trends
RSMDF RevenueRSMDF Net incomeRSMDF Net marginRSMDF Gross marginRSMDF Operating incomeRSMDF Operating marginRSMDF Operating cash flowRSMDF Free cash flowRSMDF Capital expendituresRSMDF Return on equityRSMDF Stock buybacksRSMDF Dividends paidRSMDF Total assetsRSMDF Total liabilitiesRSMDF Shareholders’ equityRSMDF overview →